Patients facing advanced neurodegenerative movement disorders endure relentless physical, cognitive, and psychosocial challenges. In routine practice, standard neurology clinics frequently struggle to manage these multifaceted demands during advanced disease stages. Consequently, integrating interdisciplinary neuropalliative care has emerged as an essential clinical priority. The Advanced Interdisciplinary Movement Disorders Supportive Care (AIMS) clinic demonstrates how specialized outpatient programs provide sustained, comprehensive care for patients often lost to follow-up.

The Imperative for Interdisciplinary Neuropalliative Care in Advanced Disease

Late-stage parkinsonian syndromes present formidable clinical challenges for outpatient practitioners. Patients experience progressive motor deficits alongside distressing neuropsychiatric symptoms, cognitive decline, dysphagia, and severe autonomic instability. Unfortunately, traditional neurology appointments prioritize acute pharmacotherapy over holistic supportive needs. Furthermore, family care partners bear extraordinary emotional and physical burdens that standard care rarely addresses. As physical disability worsens, mobility limitations prevent many patients from attending tertiary center appointments. Consequently, vulnerable individuals frequently lose access to specialized neurological expertise during critical illness phases. In addition, neurologists also encounter gaps in primary palliative skills, such as navigating complex advance care planning and managing grief. Therefore, health systems urgently need structured care delivery models that combine movement disorders expertise with comprehensive palliative support. Interdisciplinary clinics bridge this therapeutic gap effectively. By evaluating patients through a coordinated multidimensional framework, clinical teams can anticipate emergent complications before acute crises develop. Ultimately, this approach transforms reactive crisis management into proactive, compassionate clinical care.

Structural Design and Operational Workflow of the AIMS Model

Established in 2019 at an academic medical center, the AIMS clinic delivers synchronous, comprehensive outpatient evaluations. The multidisciplinary core team includes a movement disorders neurologist, clinical fellows, a neuropalliative medicine specialist, a palliative social worker, a specialized dietitian, and a nurse. Moreover, consulting specialists such as psychiatrists, neuropsychologists, and chaplains provide asynchronous support for complex clinical scenarios. During each visit, the team evaluates the patient and family care partner together. Clinicians systematically assess motor complications, nutritional intake, non-motor symptoms, caregiver distress, and advance directives. In addition, the team formulates coordinated care recommendations that align directly with patient preferences and goals. Unlike traditional consultation-only services that evaluate patients once, the AIMS model emphasizes continuous longitudinal follow-up. Patients return regularly for iterative treatment adjustments as neurodegeneration progresses. Additionally, clinic nurses maintain proactive telephone check-ins between scheduled visits to manage emerging issues promptly. Consequently, this continuous communication network resolves distress early, preventing unnecessary emergency department visits and emergency hospitalizations.

Patient Demographics and Complex Diagnostic Profiles

A retrospective review of the AIMS registry between 2019 and 2023 offers critical insights into late-stage parkinsonism populations. Overall, the study analyzed 175 consecutive patients who completed 568 total clinic visits across four years. Patients had a mean age of 72.8 years, and 57.7% were male. Remarkably, 97.5% of individuals attended appointments accompanied by an identified care partner, highlighting the profound reliance on family caregiving. Parkinson disease represented the primary diagnosis in 42.3% of patients. However, atypical parkinsonian disorders comprised a substantial proportion, including dementia with Lewy bodies (17.1%) and multiple system atrophy (12.6%). Patients experienced a median disease duration of 7.0 years from initial symptom onset to their first AIMS evaluation. Furthermore, interdisciplinary assessments resulted in revised clinical diagnoses for several individuals, clarifying prognosis and therapeutic priorities. These demographic patterns confirm that late-stage parkinsonism encompasses heterogeneous pathologies with demanding clinical trajectories. Accordingly, specialized teams must possess deep movement disorders knowledge alongside palliative expertise to deliver effective care.

Enhancing End-of-Life Transitions and Hospice Enrollment

End-of-life care for individuals with advanced parkinsonian disorders remains historically inadequate across standard healthcare systems. Nationally, Medicare data indicate low rates of hospice utilization, with referrals often occurring mere days before death. In contrast, the AIMS clinic achieved substantial improvements in terminal care coordination. Among 58 deceased patients tracked during the study period, 40 individuals (69.0%) enrolled in hospice before death. This remarkable rate exceeds published historical standards for late-stage parkinsonism. The multidisciplinary team facilitated this success by introducing goals-of-care discussions early during longitudinal clinic visits. Rather than waiting for catastrophic physical decompensation, clinicians explored patient values and preferences proactively. Additionally, the palliative social worker and clinic nurse guided families through hospice selection, dispelling common misconceptions regarding comfort care. Consequently, patients experienced smoother transitions, avoiding traumatic emergency department visits and unwanted intensive medical interventions. By establishing close relationships with community hospice agencies, the clinic ensured seamless symptom palliation through the final stages of life.

Addressing Operational Challenges in Neuropalliative Implementation

Establishing an outpatient neuropalliative clinic requires overcoming significant operational and financial barriers. Traditional fee-for-service reimbursement structures underfund prolonged multidisciplinary encounters, challenging departmental budgets. However, clinics can achieve financial sustainability by utilizing shared visit models and billing through coordinated medical and behavioral health codes. Furthermore, health systems realize broader institutional value through reduced emergency admissions and decreased acute inpatient days. Patient transportation presents another critical hurdle, as severe immobility makes travel to tertiary medical centers grueling. Therefore, adopting hybrid delivery models that blend in-person assessments with structured telehealth follow-ups substantially improves accessibility. Additionally, a limited workforce in neuropalliative medicine restricts widespread program expansion. Academic centers must address this gap by integrating neuropalliative rotations into neurology residency and fellowship curricula. As global healthcare systems shift toward value-based delivery models, interdisciplinary clinics offer a viable blueprint for high-quality, cost-effective neurodegenerative disease care.

Key Clinical Takeaways for Neurologists and Palliative Teams

Physicians managing advanced movement disorders can readily integrate core neuropalliative principles into everyday practice. First, clinicians should screen for hidden non-motor complications, including chronic pain, sleep disruption, and dysautonomia. Second, healthcare teams must evaluate family care partner burden during each clinical encounter, providing referrals to respite services and support groups. Third, practitioners should initiate advance care planning discussions early, updating documented directives as disease milestones change. Moreover, building collaborative relationships with local hospice providers facilitates timely referrals before crisis situations arise. In resource-constrained settings, primary doctors can partner with neurology specialists via telemedicine networks. Ultimately, proactive interdisciplinary coordination preserves patient dignity, relieves family caregiver distress, and elevates clinical standards in late-stage neurodegenerative disease management.

Frequently Asked Questions

How does the AIMS model differ from standard palliative consultations?

Unlike single-encounter palliative consultations that discharge patients after initial assessments, the AIMS clinic provides longitudinal, synchronous follow-up. Movement disorder neurologists and palliative specialists manage disease progression together over multiple years, ensuring persistent symptom palliation, continuous caregiver support, and seamless end-of-life transitions throughout the neurodegenerative disease course.

Which patients with parkinsonism derive the greatest benefit from neuropalliative clinics?

Patients with late-stage idiopathic Parkinson disease, progressive supranuclear palsy, multiple system atrophy, and Lewy body dementia benefit most. Candidates typically exhibit severe motor disability, recurrent falls, cognitive decline, neuropsychiatric disturbances, swallowing difficulties, or frequent hospitalizations, alongside care partners who experience substantial physical, financial, and emotional strain.

How does early neuropalliative involvement improve hospice utilization rates?

Early neuropalliative integration normalizes goals-of-care conversations well before acute terminal crises arise. Longitudinal clinicians clarify prognosis, explain hospice benefits, and address family misconceptions over time. Consequently, families embrace timely community hospice enrollment, avoiding unwanted invasive hospital interventions and ensuring dignified, comfort-focused terminal care in home settings.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals should exercise their independent clinical judgment when evaluating and treating patients. Refer to the latest local and national guidelines for clinical practice.

References

1. Husain M et al. The AIMS Clinic Model: A Retrospective Analysis of Interdisciplinary Movement-Neuropalliative Care for People With Late-Stage Parkinsonism. Neurol Clin Pract. 2026 Oct. doi: 10.1212/CPJ.0000000000200652. PMID: 42727035.
2. Creutzfeldt CJ, Kluger B, Kelly AG, et al. Neuropalliative care: Priorities to move the field forward. Neurology. 2018;91(5):217-226. doi: 10.1212/WNL.0000000000005918.
3. Kluger BM, Persenaire MJ, Holden SK, et al. Implementation issues relevant to outpatient neurology palliative care. Ann Palliat Med. 2018;7(3):339-348. doi: 10.21037/apm.2018.03.11.
4. Miyasaki JM, Long J, Mancini D, et al. Palliative care for advanced Parkinson disease: An interdisciplinary clinic model. Ann Palliat Med. 2020;9(Suppl 1):S26-S33. doi: 10.21037/apm.2019.11.08.